Latest Breaking News On - Liposome platform - Page 1 : comparemela.com

Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment

Innocan Pharma Corporation: Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment

A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant) epilepsyThe dog was frequently hospitalized to stop seizure clusters Following

Innocan Pharma Corporation: Innocan Reports Positive Results from Recent Preclinical Trial on Epileptic Seizures On a Dog using LPT: Since The Last LPT injection, Paco (dog) Has Not Had a Seizure for Over 10 weeks

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - July 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce positive results

Innocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs

Innocan Pharma Corporation: Innocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - June 10, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the successful